SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yajing Qiu, Jingyan Yang, Minyan Chen, Lei Chang, Tianyou Wang, Gang Ma, Yunbo Jin, Hui Chen, Xiaoxi Lin, A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas, The Journal of Dermatology, 2015, 42, 3
  2. 2
    Cristina Ciudad Blanco, Minia Campos Domínguez, Basilio Moreno García, Cándida Ana Villanueva Álvarez-Santullano, Beatriz Berenguer Fröhner, Ricardo Suárez Fernández, Episcleral infantile hemangioma successfully treated with topical timolol, Dermatologic Therapy, 2015, 28, 1
  3. 3
    Allyson A. Spence-Shishido, William V. Good, Eulalia Baselga, Ilona J. Frieden, Hemangiomas and the eye, Clinics in Dermatology, 2015, 33, 2, 170

    CrossRef

  4. 4
    R. Goelz, C. F. Poets, Incidence and treatment of infantile haemangioma in preterm infants, Archives of Disease in Childhood - Fetal and Neonatal Edition, 2015, 100, 1, F85

    CrossRef

  5. 5
    Steven A. Ovadia, David C. Landy, Erin R. Cohen, Ethan Y. Yang, Seth R. Thaller, Local Administration of β-Blockers for Infantile Hemangiomas, Annals of Plastic Surgery, 2015, 74, 2, 256

    CrossRef

  6. 6
    Syed Ali Raza Rizvi, Faraz Yusuf, Rajeev Sharma, Syed Wajahat Ali Rizvi, Managment of Superficial Infantile Capillary Hemangiomas with Topical Timolol Maleate Solution, Seminars in Ophthalmology, 2015, 30, 1, 62

    CrossRef

  7. 7
    Monique G. Kumar, Carrie Coughlin, Susan J. Bayliss, Outpatient Use of Oral Propranolol and Topical Timolol for Infantile Hemangiomas: Survey Results and Comparison with Propranolol Consensus Statement Guidelines, Pediatric Dermatology, 2015, 32, 2
  8. 8
    Kate Khorsand, Morgan Maier, Heather A. Brandling-Bennett, Pyogenic Granuloma in a 5-Month-Old Treated with Topical Timolol, Pediatric Dermatology, 2015, 32, 1
  9. 9
    Y. Ji, S. Chen, C. Xu, L. Li, B. Xiang, The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action, British Journal of Dermatology, 2015, 172, 1
  10. 10
    Abeer A. Tawfik, Jehan Alsharnoubi, Topical Timolol Solution Versus Laser in Treatment of Infantile Hemangioma: A Comparative Study, Pediatric Dermatology, 2015, 32, 2
  11. 11
    A. A. Cyrulnik, S. A. Glick, Update on Propranolol for Infantile Hemangioma: Where Are We Now?, NeoReviews, 2015, 16, 1, e16

    CrossRef

  12. 12
    M. Malik, R. Murphy, A pyogenic granuloma treated with topical timolol, British Journal of Dermatology, 2014, 171, 6
  13. 13
    Bernardo Gontijo, Complications of infantile hemangiomas, Clinics in Dermatology, 2014, 32, 4, 471

    CrossRef

  14. 14
    Francine Blei, Ascanio Guarini, Current workup and therapy of infantile hemangiomas, Clinics in Dermatology, 2014, 32, 4, 459

    CrossRef

  15. 15
    Katherine B. Püttgen, Diagnosis and Management of Infantile Hemangiomas, Pediatric Clinics of North America, 2014, 61, 2, 383

    CrossRef

  16. 16
    Young Woon Park, Kkot Bora Yeom, Jae Woo Choi, Dong Young Kim, Hyoseung Shin, Kyu Han Kim, Effect of propranolol on the treatment of infantile hemangiomas: a single tertiary center 3-year experience, Journal of Dermatological Treatment, 2014, 25, 5, 391

    CrossRef

  17. 17
    Gang Ma, Pinru Wu, Xiaoxi Lin, Hui Chen, Xiaojie Hu, Yunbo Jin, Yajing Qiu, Fractional Carbon Dioxide Laser–Assisted Drug Delivery of Topical Timolol Solution for the Treatment of Deep Infantile Hemangioma: A Pilot Study, Pediatric Dermatology, 2014, 31, 3
  18. 18
    Javier A. Couto, Arin K. Greene, Management of problematic infantile hemangioma using intralesional triamcinolone: Efficacy and safety in 100 infants, Journal of Plastic, Reconstructive & Aesthetic Surgery, 2014, 67, 11, 1469

    CrossRef

  19. 19
    V. Merino-Bohórquez, M. Casas, F. Caracuel, M. Cameán, M. J. Fernández-Anguita, G. Ramírez-Soto, M. J. Lucero, Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma, Pharmaceutical Development and Technology, 2014, 1

    CrossRef

  20. 20
    Jordon G. Lubahn, Richard K. Lee, Carol L. Karp, Resolution of Conjunctival Sessile Hemangioma With Topical Timolol, Cornea, 2014, 33, 1, 99

    CrossRef

  21. 21
    Young Don Kim, Sun-Ho Lee, Three Cases of Infantile Hemanioma Treated with Topical Timolol, Neonatal Medicine, 2014, 21, 2, 138

    CrossRef

  22. 22
    Lara Wine Lee, Kiera L. Goff, Joseph M. Lam, David W. Low, Albert C. Yan, Leslie Castelo-Soccio, Treatment of Pediatric Pyogenic Granulomas Using β-Adrenergic Receptor Antagonists, Pediatric Dermatology, 2014, 31, 2
  23. 23
    T. Passeron, A. Maza, E. Fontas, G. Toubel, P. Vabres, C. Livideanu, J.-M. Mazer, B. Rossi, F. Boukari, Y. Harmelin, I. Dreyfus, J. Mazereeuw-Hautier, J.-P. Lacour, Treatment of port wine stains with pulsed dye laser and topical timolol: a multicenter randomized controlled trial, British Journal of Dermatology, 2014, 170, 6
  24. 24
    Marzanna Oksiuta, Ewa Matuszczak, Wojciech Debek, Ewa Dzienis-Koronkiewicz, Adam Hermanowicz, Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature, Journal of Maternal-Fetal and Neonatal Medicine, 2014, 1

    CrossRef

  25. 25
    R Anderson, Biomedical Photonics Handbook, Second Edition, 2014,

    CrossRef

  26. 26
    Kristen E. Holland, Beth A. Drolet, Approach to the Patient with an Infantile Hemangioma, Dermatologic Clinics, 2013, 31, 2, 289

    CrossRef

  27. 27
    Shi-Qiong Xu, Ren-Bing Jia, Wei Zhang, Huang Zhu, Sheng-Fang Ge, Xian-Qun Fan, Beta-blockers versus corticosteroids in the treatment of infantile hemangioma: an evidence-based systematic review, World Journal of Pediatrics, 2013, 9, 3, 221

    CrossRef

  28. 28
    Katherine J. Willard, Mark A. Cappel, Scott H. Kozin, Joshua M. Abzug, Congenital and Infantile Skin Lesions Affecting the Hand and Upper Extremity, Part 1: Vascular Neoplasms and Malformations, The Journal of Hand Surgery, 2013, 38, 11, 2271

    CrossRef

  29. 29
    Doungdaw Chantasart, Jinsong Hao, S. Kevin Li, Evaluation of Skin Permeation of β-Blockers for Topical Drug Delivery, Pharmaceutical Research, 2013, 30, 3, 866

    CrossRef

  30. You have free access to this content30
    M. Luu, I.J. Frieden, Haemangioma: clinical course, complications and management, British Journal of Dermatology, 2013, 169, 1
  31. 31
    Y. Qiu, G. Ma, J. Yang, X. Hu, H. Chen, Y. Jin, X. Lin, Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study, Clinical and Experimental Dermatology, 2013, 38, 8
  32. 32
    Eun-Kyung Mary Kwon, Marcia Seefeldt, Beth A. Drolet, Infantile Hemangiomas, American Journal of Clinical Dermatology, 2013, 14, 2, 111

    CrossRef

  33. 33
    Kevin C. Huoh, Kristina W. Rosbe, Infantile Hemangiomas of the Head and Neck, Pediatric Clinics of North America, 2013, 60, 4, 937

    CrossRef

  34. 34
    Francine Blei, Medical and Genetic Aspects of Vascular Anomalies, Techniques in Vascular and Interventional Radiology, 2013, 16, 1, 2

    CrossRef

  35. 35
    Bogdan Cichy, Nieselektywne β-blokery w ogólnym i miejscowym leczeniu guzów naczyń, Pediatria Polska, 2013, 88, 1, 75

    CrossRef

  36. 36
    David R. Berk, Paul A. Lehman, Thomas J. Franz, Jeffrey R. Blunt, Susan J. Bayliss, On Topical Timolol Gel-Forming Solution for Infantile Hemangiomas, Pediatric Dermatology, 2013, 30, 1
  37. 37
    Ann L. Marqueling, Vikash Oza, Ilona J. Frieden, Katherine B. Puttgen, Propranolol and Infantile Hemangiomas Four Years Later: A Systematic Review, Pediatric Dermatology, 2013, 30, 2
  38. 38
    I. Dreyfus, A. Maza, J. Mazereeuw-Hautier, Quoi de neuf dans les hémangiomes infantiles ?, Archives de Pédiatrie, 2013, 20, 7, 809

    CrossRef

  39. 39
    A. Mouhari-Toure, K.-D. Azoumah, K. Tchamdja, B. Saka, K. Kombaté, K. Tchangaï-Walla, P. Pitche, Régression rapide d’un hémangiome infantile sous propranolol topique à 2 %, Annales de Dermatologie et de Vénéréologie, 2013, 140, 6-7, 462

    CrossRef

  40. 40
    M.L. Lam, A.N. Patel, A.D. Ferguson, Review of the 92nd Annual Meeting of the British Association of Dermatologists, 3–5 July 2012, Birmingham, U.K, British Journal of Dermatology, 2013, 168, 1
  41. 41
    Hadar Lev-Tov, Sara Dahle, Joyce Moss, Roslyn R. Isseroff, Successful treatment of a chronic venous leg ulcer using a topical beta-blocker, Journal of the American Academy of Dermatology, 2013, 69, 4, e204

    CrossRef

  42. 42
    Jennifer Sorrell, Sarah L. Chamlin, Topical Timolol 0.5% Gel-Forming Solution for Small Deep Facial Infantile Hemangiomas, Pediatric Dermatology, 2013, 30, 5
  43. 43
    Ewa Matuszczak, Marzanna Oksiuta, Wojciech Dębek, Ewa Dzienis-Koronkiewicz, Adam Hermanowicz, Topical timolol gel for the treatment of residual facial hemangioma previously treated with propranolol, Pediatria Polska, 2013, 88, 1, 116

    CrossRef

  44. 44
    K. Semkova, J. Kazandjieva, Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study, Clinical and Experimental Dermatology, 2013, 38, 2
  45. 45
    Kachiu C. Lee, Lionel Bercovitch, Update on infantile hemangiomas, Seminars in Perinatology, 2013, 37, 1, 49

    CrossRef

  46. You have free access to this content46
    Martin Theiler, Regula Wälchli, Lisa Weibel, Vascular anomalies – a practical approach, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2013, 11, 5
  47. 47
    Howard B. Pride, Megha Tollefson, Robert Silverman, What's new in pediatric dermatology?, Journal of the American Academy of Dermatology, 2013, 68, 6, 899.e1

    CrossRef

  48. 48
    Kathryn C Durham, Adelaide A Hebert, A β-antagonist for the treatment of infantile hemangiomas, Clinical Practice, 2012, 9, 6, 611

    CrossRef

  49. 49
    Alison B. Callahan, Michael K. Yoon, Infantile hemangiomas: A review, Saudi Journal of Ophthalmology, 2012, 26, 3, 283

    CrossRef

  50. 50
    Marcia Hogeling, Propranolol for Infantile Hemangiomas: A Review, Current Dermatology Reports, 2012, 1, 4, 179

    CrossRef

  51. 51
    S. Barbarot, Quoi de neuf en dermatologie pédiatrique ?, Annales de Dermatologie et de Vénéréologie, 2012, 139, S202

    CrossRef

  52. 52
    Patrick McMahon, Vikash Oza, Ilona J. Frieden, Topical Timolol for Infantile Hemangiomas: Putting a Note of Caution in “Cautiously Optimistic”, Pediatric Dermatology, 2012, 29, 1
  53. 53
    Christine Lauren, Maria C. Garzon, Treatment of Infantile Hemangiomas, Pediatric Annals, 2012, 41, 8, 1

    CrossRef

  54. 54
    Francine Blei, Update March 2012, Lymphatic Research and Biology, 2012, 10, 1, 33

    CrossRef